help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hershberger, R. E.
Right arrow Articles by Stork, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hershberger, R. E.
Right arrow Articles by Stork, P. J.

Endocrinology, Vol 134, 1277-1285, Copyright © 1994 by Endocrine Society


ARTICLES

The somatostatin receptors SSTR1 and SSTR2 are coupled to inhibition of adenylyl cyclase in Chinese hamster ovary cells via pertussis toxin- sensitive pathways

RE Hershberger, BL Newman, T Florio, J Bunzow, O Civelli, XJ Li, M Forte and PJ Stork
Vollum Institute for Advanced Biomedical Research, Oregon Health Sciences University, Portland 97201.

Somatostatin exerts multiple effects throughout the body by binding to specific somatostatin receptors. Two classes of somatostatin receptors, SRIF1 and SRIF2, have been distinguished biochemically and pharmacologically. Two cDNAs have been recently isolated that encode somatostatin receptors 1 and 2 (SSTR1 and SSTR2, respectively). The pharmacological characteristics of receptors expressing these cDNAs resemble those of the SRIF2 and SRIF1 classes of somatostatin receptors, respectively. We stably expressed the rat homologs of both receptors in Chinese hamster ovary (CHO) cells (type K1). These transfected cell lines recognized the endogenous ligands SS14 and SS28 with high affinity, whereas the synthetic analog MK678 identified only SSTR2. In preparations of CHO-SSTR1 or CHO-SSTR2 cells, SS14 and SS28 inhibited forskolin-stimulated adenylyl cyclase activity by approximately 35%, with ED50 values in the nanomolar range. The adenylyl cyclase inhibition was dependent upon the guanine nucleotide GTP and could be ablated with pertussis toxin preincubation. The present data indicate that SSTR1 and SSTR2 are coupled to inhibition of adenylyl cyclase via pertussis toxin- sensitive G-proteins.


This article has been cited by other articles:


Home page
EndocrinologyHome page
P. A. Smith
N-Type Ca2+-Channels in Murine Pancreatic {beta}-Cells Are Inhibited by an Exclusive Coupling with Somatostatin Receptor Subtype 1
Endocrinology, February 1, 2009; 150(2): 741 - 748.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Arena, A. Pattarozzi, A. Massa, J.-P. Esteve, R. Iuliano, A. Fusco, C. Susini, and T. Florio
An Intracellular Multi-Effector Complex Mediates Somatostatin Receptor 1 Activation of Phospho-Tyrosine Phosphatase {eta}
Mol. Endocrinol., January 1, 2007; 21(1): 229 - 246.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Duran-Prado, C. Bucharles, B. J. Gonzalez, R. Vazquez-Martinez, A. J. Martinez-Fuentes, S. Garcia-Navarro, S. J. Rhodes, H. Vaudry, M. M. Malagon, and J. P. Castano
Porcine Somatostatin Receptor 2 Displays Typical Pharmacological sst2 Features but Unique Dynamics of Homodimerization and Internalization
Endocrinology, January 1, 2007; 148(1): 411 - 421.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Arena, A. Pattarozzi, A. Corsaro, G. Schettini, and T. Florio
Somatostatin Receptor Subtype-Dependent Regulation of Nitric Oxide Release: Involvement of Different Intracellular Pathways
Mol. Endocrinol., January 1, 2005; 19(1): 255 - 267.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Q. Liu, J.-C. Reubi, Y. Wang, B. J. Knoll, and A. Schonbrunn
In Vivo Phosphorylation of the Somatostatin 2A Receptor in Human Tumors
J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 6073 - 6079.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
T. Florio, H. Yao, K. D. Carey, T. J. Dillon, and P. J. S. Stork
Somatostatin Activation of Mitogen-Activated Protein Kinase via Somatostatin Receptor 1 (SSTR1)
Mol. Endocrinol., January 1, 1999; 13(1): 24 - 37.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Caron, L. Buscail, A. Beckers, J.-P. Esteve, A. Igout, G. Hennen, and C. Susini
Expression of Somatostatin Receptor SST4 in Human Placenta and Absence of Octreotide Effect on Human Placental Growth Hormone Concentration during Pregnancy
J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3771 - 3776.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Y.-Z. Gu and A. Schonbrunn
Coupling Specificity between Somatostatin Receptor sst2A and G Proteins: Isolation of the Receptor-G Protein Complex with a Receptor Antibody
Mol. Endocrinol., May 1, 1997; 11(5): 527 - 537.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. G. Eason and S. B. Liggett
Identification of a G(s) Coupling Domain in the Amino Terminus of the Third Intracellular Loop of the alpha[IMAGE]-Adrenergic Receptor
J. Biol. Chem., October 20, 1995; 270(42): 24753 - 24760.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. Liu and A. Schonbrunn
Agonist-induced Phosphorylation of Somatostatin Receptor Subtype 1 (Sst1). RELATIONSHIP TO DESENSITIZATION AND INTERNALIZATION
J. Biol. Chem., January 26, 2001; 276(5): 3709 - 3717.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society